首页|不同抗体亚型抗合成酶综合征并发间质性肺疾病临床特征分析

不同抗体亚型抗合成酶综合征并发间质性肺疾病临床特征分析

Analysis of the clinical characteristics of different antibody sub-types of anti-syntheses syndrome complicated with lung interstitial lung disease

扫码查看
目的 总结不同抗体亚型抗合成酶综合征(ASS)并发间质性肺疾病(ILD)患者的临床特征差异.方法 回顾性分析2019年12月至2023年6月就诊于南京医科大学第一附属医院(江苏省人民医院)的132例ASS-ILD患者的基本信息、临床特征、实验室检查、胸部CT及肺功能等资料,并根据抗氨酰tRNA合成酶(ARS)抗体分为不同亚型.对于正态分布且方差齐的采用两独立样本t检验比较,非正态分布计量资料采用Mann-Whitney U检验比较,对二分类变量资料使用x2检验或Fisher确切概率法进行比较.结果 132例ASS-ILD患者中抗合成酶抗体亚型以抗组氨酸抗体(Jo-1)最常见(60/132,45.5%),其次为抗甘氨酸基tRNA合成酶抗体(EJ)(33/132,25.0%)、抗苏氨酸基tRNA合成酶抗体(PL-7)(26/132,19.7%)、抗丙氨酸基tRNA合成酶抗体(PL-12)阳性(10/132,7.6%)、抗异亮氨酸基tRNA合成酶(OJ)抗体阳性(3/132,2.2%).抗合成酶抗体合并抗Ro-52双阳性的ASS患者合并快速进展型ILD的比例显著增加.不同亚型ASS-ILD患者中抗Jo-1抗体阳性组合并感染28例(46.7%),合并关节炎/痛27例(45.0%),较其他组更常见(P<0.05);抗EJ抗体阳性组有显著肺功能下降,且咳嗽31例(93.9%)较其他组更常见(x2=0.15,P=0.047);抗PL-12抗体阳性组肺功能下降较其他组明显(P<0.05),且发热(7例,70.0%)较其他组更常见(x2=0.02,P=0.022).结论 不同抗合成酶抗体亚型中抗Jo-1、抗PL-7、抗PL-12等抗体亚型在ILD更常见,抗PL-12和抗EJ抗体阳性患者肺功能下降明显.
Objective To summarize the clinical characteristics in of different antibody subtypes in of patients with antisynthetase syndrome(ASS)complicated with interstitial lung disease(ILD).Methods A retrospective analysis was conducted on 132 ASS-ILD patients at the First Affiliated Hospital of Nanjing Medical University(Jiangsu Provincial People's Hospital),encompassing a period from December 2019 to June 2023.The data included were basic demographic information,clinical features,laboratory test results,chest computed tomography(CT)scans,and pulmonary lung function tests.Patients were categorized into distinct subtypes based on anti-aminoacyl tRNA synthetase(ARS)antibodies.Statistical analysis was performed using a t-test for comparing means between two samples with equal variance,the Mann-Whitney U test for non-normally distributed continuous data,and the chi-square(x2)test or Fisher's exact test for categorical variables.Results The most prevalent subtype of anti-synthetase antibody was anti-histidine antibody(Jo-1),accounting for 60 of 132 cases(45.5%),followed by anti-glycine-based tRNA synthetase antibody(EJ)(33/132,2 5.0%),anti-tRNA synthase antibody(PL-7)(26/132,19.7%),anti-alanine-based tRNA synthetase antibody(PL-12)(7.6%,10/132),anti-isoleucine-tRNA synthase antibody(OJ)(3/132,2.2%).The presence of anti-Ro-52 antibodies was significantly associated with rapidly progressive ILD.In patients with different subtypes of ASS-ILD,the presence of anti-Jo-1 antibodies is was positive in 28 cases(46.7%),and the combination of infection is was more common than in other groups(x2=0.15,P=0.047).The group with positive anti-EJ antibodies has had a significant decline in lung function,and cough is was more common in 31 cases(93.9%)than in other groups(P<0.05);the group with positive anti-PL-12 antibodies has had a more pronounced decline in lung function than other groups(P<0.05),and fever(7 cases,70.0%)wais more common than in other groups(x2=0.02,P=0.022).Conclusion Anti-Jo-1,Anti-PL-7,and Anti-PL-12 antibodies were are observed more frequently in patients with ILD.Furthermore,a significant deterioration in lung function was is observed in patients testing positive for anti-PL-12 and anti-EJ antibodies.

Antisynthetase syndromeLung disease,interstitialClinical characteristicsAnti-synthetase antibody

周云、吕成银、尤含笑、徐凌霄、谈文峰、朱玉静

展开 >

南京医科大学第一附属医院(江苏省人民医院)风湿免疫科,南京 210029

江苏省沐阳医院风湿科,沐阳 223600

抗合成酶综合征 肺疾病,间质性 临床特征 抗合成酶抗体

国家自然科学基金国家自然科学基金国家自然科学基金国家自然科学基金

81971532821717948197153382271844

2024

中华风湿病学杂志
中华医学会

中华风湿病学杂志

CSTPCD
影响因子:0.651
ISSN:1007-7480
年,卷(期):2024.28(8)